Hot Keywords
Non-small cell lung cancer Artificial intelligence Gastroesophageal reflux Esophagectomy Thoracic surgery Atherosclerosis Robotic surgery Gastric cancer Lung cancer Lobectomy Complications Quality of life Rectal cancer

Mini-invasive Surg 2021;5:[Accepted].10.20517/2574-1225.2021.47@The Author(s) 2021
Accepted Manuscript
Open AccessReview

Hybrid coronary revascularization in patients with type 2 diabetes

Correspondence Address: Dr. Rodrigo M. do Lago, FACC, Cardiology Department, Advent Health Hospital, 601 E Rollins St Suite 400, Orlando, FL 32803, USA. E-mail: Rodrigo.marinasdolago.md@adventhealth.com; Xuan.guan.md@adventhealth.com


© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.


Type 2 diabetes is very prevalent. Patients with diabetes and coronary disease have a higher likelihood to develop a more diffuse and progressive atherosclerotic vascular disease with multivessel coronary artery disease and experience worse overall outcomes than nondiabetic patients when undergoing coronary revascularization. Understanding the optimal strategy to treat patients with diabetes and multivessel coronary disease is essential. Hybrid coronary revascularization is a strategic approach to treat selected patients with multivessel coronary disease and may benefit patients with diabetes in the low to intermediate spectrum of coronary disease complexity that have non-left anterior descendent coronary lesions amenable for percutaneous revascularization and associated complex left anterior descendent lesion not ideal for percutaneous coronary intervention. This strategy may mitigate some of the comorbidities associated with surgical revascularization and provide the long-term benefit of the arterial conduit to the left anterior descendent coronary. More studies are needed to better understand the subset of diabetic patients that would derive the most benefit from such approach.

Cite This Article

do Lago RM, Guan X. Hybrid coronary revascularization in patients with type 2 diabetes. Mini-invasive Surg 2021;5:[Accept]. http://dx.doi.org/10.20517/2574-1225.2021.47

© 2016-2021 OAE Publishing Inc., except certain content provided by third parties